Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Baxter International
(NY:
BAX
)
37.54
+1.05 (+2.88%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Baxter International
< Previous
1
2
3
4
5
6
7
Next >
Rivian, Chipotle Mexican And Sirius XM Are Among Top 10 Large Cap Losers Last Week (Aug 11-Aug 17): Are The Others In Your Portfolio?
August 18, 2024
Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all seeing declines.
Via
Benzinga
Baxter Tumbles On $3.8 Billion Kidney Deal — Why Investors Expected More
August 13, 2024
The company is selling its Vantive Kidney Care business to Carlyle, a private equity investor in the medtech space.
Via
Investor's Business Daily
Baxter Seals $3.8B Deal With Carlyle For Its Kidney Care Segment
August 13, 2024
Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, with net after-tax proceeds estimated at $3 billion. Post-sale, Baxter...
Via
Benzinga
The Latest Analyst Ratings For Baxter Intl
August 07, 2024
Via
Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Assessing Baxter Intl: Insights From 4 Financial Analysts
July 02, 2024
Via
Benzinga
How Is The Market Feeling About Baxter Intl?
June 07, 2024
Via
Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
May 30, 2024
Via
Benzinga
Baxter Lifts Annual Outlook After Strong Q2 Beat, Medical Devices Sales
August 06, 2024
Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant currency, driven by Pharmaceuticals, Medical Products, and Healthcare...
Via
Benzinga
3 Contrarian Stock Picks to Buy Against the Market Consensus
August 05, 2024
Discover three contrarian stock picks with strong fundamentals that defy current market trends and offer significant rebound potential.
Via
InvestorPlace
Carlyle's $4B Purchase Of Baxter's Kidney Division Backed By Ares And HPS Financing
July 24, 2024
Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of Baxter's kidney-care division, highlighting the evolving role of private...
Via
Benzinga
AutoNation, Baxter International And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 15, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
July 10, 2024
Via
Benzinga
(BAX) - Analyzing Baxter Intl's Short Interest
May 13, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
May 10, 2024
Via
Benzinga
3 Bargain Bin Stocks with Millionaire-Maker Potential
July 09, 2024
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks.
Via
InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
July 08, 2024
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and...
Via
Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
July 04, 2024
Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
7 Deeply Undervalued Stocks to Buy Now or Regret Later
June 05, 2024
Unlock massive upside by buying these deeply undervalued stocks at fire-sale prices. These companies have staying power and could bounce back.
Via
InvestorPlace
3 Dividend Growth Stocks For Long-Term Returns
May 24, 2024
One way to measure the quality of a dividend stock is by its dividend history. Stocks with established histories of dividend growth may be likely to continue growing their dividends moving forward....
Via
Talk Markets
3 Dividend Stocks For 10%+ Annual Returns
April 26, 2024
Buying undervalued dividend stocks with growth potential could lead to above-average returns.
Via
Talk Markets
Assessing Baxter Intl: Insights From 4 Financial Analysts
April 03, 2024
Via
Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
May 21, 2024
Via
Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
May 17, 2024
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...
Via
Benzinga
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
May 06, 2024
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger.
Via
InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
May 03, 2024
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.
Via
InvestorPlace
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
May 02, 2024
Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 02, 2024
Via
Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
April 01, 2024
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability.
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.